Silymarin Bioavailability Study

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 20, 2024

Study Completion Date

January 31, 2025

Conditions

Bioavailability and Pharmacokinetics

Interventions

DIETARY_SUPPLEMENT

LipoMicel Milk Thistle

A maximum single dose of approx. 140 mg silymarin (in soft gel capsule)

DIETARY_SUPPLEMENT

Unformulated Milk Thistle Extract

A maximum single dose of approx. 130 mg silymarin (in hard gel capsules)

Trial Locations (1)

ISURA, Burnaby

All Listed Sponsors

lead

Isura

OTHER

NCT06882681 - Silymarin Bioavailability Study | Biotech Hunter | Biotech Hunter